References
- Huntington Study Group. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology. 2006;66(3):366–372.
- Huntington Study Group. Dosage effects of riluzole in Huntington's disease: a multicenter placebo-controlled study. Neurology. 2003; 61:1551–1556.
- Puri BK, Leavitt BR, Hayden MR, Ross CA, Rosenblatt A, Greenamyre JT, Hersch S, Vaddadi KS, Sword A, Horrobin DF, Manku M, Murck H. Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial. Neurology. 2005; 65(2):286–292.
- van Vugt JP, Siesling S, Vergeer M, van der Velde EA, Roos RA. Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study. J Neurol Neurosurg Psychiatry. 1997;63(1):35–39.
- Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Orme C, Paulsen J, Penney JB, Jr., Siemers E, Shoulson I. Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology. 2000;54(2):452–458.
- Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clamette R, Lee E, Lyons B, Grossman F. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry. 2003;64(2):134–143.
- De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Bums A. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. Clin Neurol Neurosurg. 2005;107(6):497–508.
- Parsa MA, Szigethy E, Voci JM, Meltzer HY. Risperidone in treatment of choreoathetosis of Huntington's disease. J Clin Psychopharmacol. 1997;17(2):134–135.
- Erdemoglu AK, Boratav C. Risperidone in chorea and psychosis of Huntington's disease. Eur J NeuroL 2002;9(2):182–183.
- Madhusoodanan S. Brenner R. Use of risperidone in psychosis associated with Huntington's disease. Am J Geriatr Psychiatry. 1998;6(4):347–349.
- Dallocchio C, Buffa C, Tinelli C, Mazzarello P. Effectiveness of risperidone in Huntington chorea patients. J Clin Psychopharma-col. 1999;19(1):101–103.
- Shoulson I, Kurlan R, Rubin A. Assessment of functional capac-ity in neurodegenerative disorders: Huntington's disease as a pro-totype, In: Munsat TL. Quantification of Neurologic Deficits. Boston, Butterworth; 1989;285–309.
- Beglinger LJ, Langbehn DR, Duff K, Stierman L, Black DW, Nehl C, Anderson K, Penziner E, Paulsen JS. Probability of Obsessive and Compulsive symptoms in Huntington's Disease. Biol Psychiatry. 2007;61:415–418.
- Potkin SG, Gharabawi GM, Greenspan AJ, Mahmoud R, Kosik-Gonzalez C, Rupnow MF, Bossie CA, Davidson M, Burtea V, Zhu Y, Trivedi JK. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experienc-ing an acute exacerbation requiring hospitalization. Schizophr Res. 2006;85(1-3):254–265.